跳到正文
原文
STAT Pharma 医药频道· John Wilkerson·· 2026-09-30AI 评分24

STAT+:FDA 局长提名人 Heidi Overton 未能在中期选举前获参议院卫生委员会投票

STAT+: Overton won’t get a vote before midterms

AI 导读

美国参议院卫生委员会本周三将就三名 HHS 提名人进行投票,但 FDA 局长提名人 Heidi Overton 不在其中。参议院休会至 11 月 9 日,Overton 的提名投票将推迟到中期选举之后。此前一周的听证会未能明确关键共和党议员的投票意向,而委员会中只需一名共和党人反对即可否决其提名。

正文

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

Love is Blind is coming to Boston to spill some tea. Send news tips and casting suggestions/exes to John.Wilkerson@statnews.com or John_Wilkerson.07 on Signal.

The need-to-know this week

  • Wednesday is the deadline for states to decide whether to participate in GENEROUS, a pilot program offering drugs in Medicaid at prices available abroad.

  • The Senate health committee will vote Wednesday on three HHS nominees. Heidi Overton, the nominee to lead the Food and Drug Administration, is not among them. (More on that below.)

  • CMS Administrator Mehmet Oz will be in Texas to talk up CHOICE arrangements, in which employers can give workers money tax-free to buy ACA Marketplace insurance.

  • The annual U.S. Alcohol Policy Alliance conference is taking place in Arlington. It’s the main group advocating for stronger alcohol regulation.

Why no Overton?

It would take just one Republican to sink Overton’s nomination in committee, and last week’s hearing didn’t shed much light on how hard-to-get Republicans might vote. Now we will not know until after the elections. This is the last week the Senate is in session until Nov. 9., and the Senate’s health committee doesn’t have a vote scheduled on the nominee to run the FDA.

Continue to STAT+ to read the full story…

来源:STAT Pharma 医药频道 · statnews.com